Research graph

References

References from Addition of histamine to IL-2 treatment augments T1 cell-function in melanoma patients in vivo: results from a randomized clinical trial of IL-2 with or without histamine (MP 104). Local targets link to admitted publications; unresolved targets remain external evidence.

No reference evidence is available for this admitted work.